Lupus News and Research

Latest Lupus News and Research

Study establishes a feasible combination therapeutic strategy for ulcerative colitis

Despite recent advancements in our knowledge of the pathogenic mechanisms of ulcerative colitis, there is still a considerable unmet medical need for the treatment of ulcerative colitis.

29 Sep 2022

Duration of infectiousness, predictors of ongoing individual infectiousness, and diagnostic tests for acute SARS-CoV-2 infection

Researchers explored SARS-CoV-2 variants of concern/interest (VOC/VOI) kinetics and variations among non-hospitalized acute COVID-19 patients.

29 Sep 2022

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

In a new study, a team of researchers explored the effect of immune checkpoint blockade (ICB)-induced expansion of age-associated B cells (ABCs) on COVID-19 vaccine-derived humoral immunity in patients with cancer and inborn errors of immunity (IEI).

22 Sep 2022

Patients with autoimmune diseases at greater risk of complications after heart attack

In a recent study published in the Journal of the American Heart Association, researchers assessed midterm and management outcomes of acute myocardial infarction (AMI) among patients with rheumatic immune-mediated inflammatory diseases (IMIDs).

18 Sep 2022

New data analysis approach could help uncover the genetic basis of many diseases

In the era of Big Data, obtaining a huge amount of information is the easy part; knowing what to do with it is another story entirely.

9 Sep 2022

Novel 3D-printed light-sensing medical device could help millions of lupus patients

A team of engineers and doctors at the University of Minnesota Twin Cities have designed a unique 3D-printed light-sensing medical device that is placed directly on the skin and gives real-time feedback to correlate light exposure with disease flare-ups.

8 Sep 2022

Clinical trial shows efficacy and safety of belimumab in East Asian adults with lupus nephritis

This prespecified subgroup analysis of East Asian adults who participated in a phase 3 clinical trial of belimumab added to standard therapy vs. placebo added to standard therapy for lupus nephritis shows earlier and more sustained improvement in kidney outcomes with the addition of belimumab.

2 Sep 2022

The origins, breadth, and resolution of autoreactivity in severe COVID-19

Researchers assessed naïve B cells and autoreactivity in severe COVID-19.

2 Sep 2022

People with autoimmune disorder have a higher risk of developing cardiovascular disease

Around ten percent of the population in high income regions like Europe and the United States has been diagnosed with one or multiple autoimmune disorders.

29 Aug 2022

Study reveals safety and uptake of sotrovimab against severe SARS-CoV-2 infection in England

In a newly released study, researchers explored the sotrovimab uptake for severe COVID-19 prophylaxis and its safety across the community populations in England.

22 Aug 2022

Scientists begin phase 2 clinical trials of lupus pill

Lupus is an autoimmune disease that attacks organs and can be fatal. There's no cure, so current treatments aim to limit damage and ameliorate symptoms.

22 Aug 2022

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

A recent article illustrated the derivation and validation of the QCOVID4 risk determination algorithm for predicting COVID-19 hospitalization and death risk in England.

18 Aug 2022

New anti-cancer drug candidate is absorbed through the lymphatic system rather than blood vessels

A team of University of Michigan researchers is developing a new anti-cancer drug that is absorbed through the gut's lymphatic system rather than blood vessels, potentially outmaneuvering the molecular signaling pathways that lead to drug resistance while increasing cancer-fighting ability and reducing side effects.

17 Aug 2022

Clinical and demographic inequalities in COVID-19-associated mortality

Researchers quantified the relative and absolute changes in COVID-19-related mortality based on clinical and demographical profiles of 18 million adult patients throughout the pandemic in England.

4 Aug 2022

ADAR1 mutation sets off biochemical pathways that produce an organ-damaging autoimmune response

A new study shows how mutation of the ADAR1 gene sets off biochemical pathways that produce an autoimmune response that harms the developing brain and other areas of the body.

2 Aug 2022

Because of Texas abortion law, her wanted pregnancy became a medical nightmare

New, untested abortion bans have made doctors unsure about treating some pregnancy complications, which has led to life-threatening delays and trapped families in a limbo of grief and helplessness.

2 Aug 2022

Three things about the abortion debate that many people get wrong

In the wake of the Supreme Court's decision to overturn the federal right to abortion, things are more than a little confused.

22 Jul 2022

UT Southwestern physicians outline the risks of pregnancy in women with rheumatic disease

Pregnant women with active rheumatic disease carry a higher risk of adverse outcomes than the general population including hypertension, preeclampsia, higher cesarean section rate, small for gestational aged infants, preterm delivery, and fetal loss. To

19 Jul 2022

Chemokine-DNA nanoparticles can induce chronic, dysfunctional immune responses

Small proteins, called chemokines, that direct immune cells toward sites of infection can also form DNA-bound nanoparticles that can induce chronic, dysfunctional immune responses, according to a new study by researchers at Weill Cornell Medicine and Hospital for Special Surgery (HSS).

15 Jul 2022

Video game intervention improves attention and executive functioning in patients with lupus

A National Jewish Health led study recently published in Lupus finds that technology through video game-based cognitive therapy improves attention and executive functioning in patients with systemic lupus erythematosus (SLE).

14 Jul 2022

Lupus News and Research

Latest Lupus News and Research

Study establishes a feasible combination therapeutic strategy for ulcerative colitis

Duration of infectiousness, predictors of ongoing individual infectiousness, and diagnostic tests for acute SARS-CoV-2 infection

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

Patients with autoimmune diseases at greater risk of complications after heart attack

New data analysis approach could help uncover the genetic basis of many diseases

Novel 3D-printed light-sensing medical device could help millions of lupus patients

Clinical trial shows efficacy and safety of belimumab in East Asian adults with lupus nephritis

The origins, breadth, and resolution of autoreactivity in severe COVID-19

People with autoimmune disorder have a higher risk of developing cardiovascular disease

Study reveals safety and uptake of sotrovimab against severe SARS-CoV-2 infection in England

Scientists begin phase 2 clinical trials of lupus pill

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

New anti-cancer drug candidate is absorbed through the lymphatic system rather than blood vessels

Clinical and demographic inequalities in COVID-19-associated mortality

ADAR1 mutation sets off biochemical pathways that produce an organ-damaging autoimmune response

Because of Texas abortion law, her wanted pregnancy became a medical nightmare

Three things about the abortion debate that many people get wrong

UT Southwestern physicians outline the risks of pregnancy in women with rheumatic disease

Chemokine-DNA nanoparticles can induce chronic, dysfunctional immune responses

Video game intervention improves attention and executive functioning in patients with lupus

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lupus News and Research

Latest Lupus News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in